Machine Learning Application for Medicinal Chemistry: Colchicine Case, New Structures, and Anticancer Activity Prediction

Damian Nowak,Adam Huczyński,Rafał Adam Bachorz,Marcin Hoffmann

DOI: https://doi.org/10.3390/ph17020173

IF: 4.6

2024-01-30

Pharmaceuticals

Abstract:In the contemporary era, the exploration of machine learning (ML) has gained widespread attention and is being leveraged to augment traditional methodologies in quantitative structure–activity relationship (QSAR) investigations. The principal objective of this research was to assess the anticancer potential of colchicine-based compounds across five distinct cell lines. This research endeavor ultimately sought to construct ML models proficient in forecasting anticancer activity as quantified by the IC50 value, while concurrently generating innovative colchicine-derived compounds. The resistance index (RI) is computed to evaluate the drug resistance exhibited by LoVo/DX cells relative to LoVo cancer cell lines. Meanwhile, the selectivity index (SI) is computed to determine the potential of a compound to demonstrate superior efficacy against tumor cells compared to its toxicity against normal cells, such as BALB/3T3. We introduce a novel ML system adept at recommending novel chemical structures predicated on known anticancer activity. Our investigation entailed the assessment of inhibitory capabilities across five cell lines, employing predictive models utilizing various algorithms, including random forest, decision tree, support vector machines, k-nearest neighbors, and multiple linear regression. The most proficient model, as determined by quality metrics, was employed to predict the anticancer activity of novel colchicine-based compounds. This methodological approach yielded the establishment of a library encompassing new colchicine-based compounds, each assigned an IC50 value. Additionally, this study resulted in the development of a validated predictive model, capable of reasonably estimating IC50 values based on molecular structure input.

pharmacology & pharmacy,chemistry, medicinal

What problem does this paper attempt to address?

### Problems the Paper Aims to Solve This paper aims to address the following key issues through machine learning methods: 1. **Predicting Antitumor Activity**: Evaluate the antitumor potential of colchicine-based compounds in 5 different cell lines and build machine learning models that can predict the antitumor activity of these compounds (measured by IC50 values). 2. **Generating New Structures**: Generate new colchicine derivative compounds and predict their antitumor activity. 3. **Pharmacodynamic Evaluation**: Calculate the Resistance Index (RI) and Selectivity Index (SI) to assess the efficacy of compounds across different cell lines. Specifically, the research aims to predict IC50 values in 5 cell lines, including: - A549 (lung adenocarcinoma-related cell line) - BALB/3T3 (normal cell line used to detect the carcinogenic potential of chemical substances) - LoVo/DX (doxorubicin-resistant human colon adenocarcinoma cell line) - LoVo (human colon adenocarcinoma cell line) - MCF-7 (breast cancer-related cell line) Additionally, the research has developed a validated predictive model that can reasonably estimate IC50 values based on molecular structure inputs and generate a library containing new colchicine-based compounds. These compounds can be screened for further experimental validation.

Machine Learning Application for Medicinal Chemistry: Colchicine Case, New Structures, and Anticancer Activity Prediction

An insight into the anticancer potential of carbamates and thiocarbamates of 10-demethoxy-10-methylaminocolchicine

Identifying High-Quality Leads among Screened Anticancerous Compounds Using SMILES Representations

MLASM: Machine learning based prediction of anticancer small molecules

Elucidating Molecular Mechanism and Chemical Space of Chalcones through Knowledge Graph and Machine Learning: A Combined Bio-Cheminformatic Pipeline

Predicting antimicrobial class specificity of small molecules using machine learning

Reliable anti-cancer drug sensitivity prediction and prioritization

Elucidating molecular mechanism and chemical space of chalcones through biological networks and machine learning approaches

Prediction of Antibacterial Compounds by Machine Learning Approaches

Computer-aided drug design to discover DNMT inhibitors from phytochemicals

Development of Machine Learning-based QSAR Models for the Designing of Novel Anti-cancer Therapeutics Against Malignant Glioma

Prediction of Compound Cytotoxicity Based on Compound Structures and Cell Line Molecular Characteristics

Machine learning approaches for predicting compounds that interact with therapeutic and ADMET related proteins.

Initial Development of Automated Machine Learning-Assisted Prediction Tools for Aryl Hydrocarbon Receptor Activators

Machine Learning for Active Sites Prediction of Quinoline Derivatives

Structural Analysis for Colchicine Binding Site-Targeted Atcaa Derivatives As Melanoma Antagonists

Molecular modelling of antiproliferative inhibitors based on SMILES descriptors using Monte-Carlo method, docking, MD simulations and ADME/Tox studies

Prediction of Cancer Cell Sensitivity to Natural Products Based on Genomic and Chemical Properties.

Machine learning and data mining frameworks for predicting drug response in cancer: An overview and a novel in silico screening process based on association rule mining

Computational modeling of methionine cycle-based metabolism and DNA methylation and the implications for anti-cancer drug response prediction

What are the current challenges for machine learning in drug discovery and repurposing?